{"id":"W2168579528","doi":"10.1016/s1470-2045(13)70154-2","title":"Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":654,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"National Institutes of Health; Institute of Cancer Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; F. Hoffmann-La Roche","keywords":"Capecitabine; Medicine; Bevacizumab; Internal medicine; Irinotecan; Colorectal cancer; Hazard ratio; Clinical endpoint; Oxaliplatin; Adverse effect; Oncology; Population; Cancer; Randomized controlled trial; Chemotherapy; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004238308,0.0004476239,0.001994694,0.0001212874,0.0002149353,0.00006826624,0.0004199024,0.0001162936,0.00109658],"category_scores_gemma":[0.000185975,0.0002528836,0.00005703213,0.0004775462,0.0002883559,0.0002746817,0.0001581196,0.0003787011,0.00004089069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001315056,"about_ca_system_score_gemma":0.0007195428,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.006675649,"about_ca_topic_score_gemma":0.02527192,"domain_scores_codex":[0.9971182,0.0004929546,0.0006247403,0.0005871727,0.0003625489,0.0008143731],"domain_scores_gemma":[0.9981194,0.0005410101,0.0003147205,0.0004732918,0.0003283707,0.0002231868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9297702,0.005495191,0.00143445,0.00004483897,0.001243968,0.0001405864,0.002227538,0.0000184968,0.0003477851,0.0000239909,0.001891433,0.05736152],"study_design_scores_gemma":[0.9241968,0.05920648,0.01129671,0.00006931159,0.0009945101,0.00001691035,0.0003758174,0.0003825999,0.00009886155,0.0000384112,0.0030199,0.0003036669],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819716,0.0008351921,0.000004619072,0.002961465,0.00057799,0.01009613,0.0001022712,0.0000722585,0.003378429],"genre_scores_gemma":[0.9919069,0.0003840311,0.00049284,0.0004779059,0.0003971311,0.005576536,0.0002802889,0.00005545378,0.0004288665],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05705786,"threshold_uncertainty_score":0.9999923,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06574882485102473,"score_gpt":0.374869717678169,"score_spread":0.3091208928271442,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}